Patent US4264709A successfully refreshed from Google Patents.
Patent US290958A successfully refreshed from Google Patents.
Patent US2907692A successfully refreshed from Google Patents.
US2907692A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Composition for treating diabetes and a process of administering same
Assignee: Roche Diagnostics GmbH
•
Filing: 1955-08-30
•
Granted: 1959-10-06
•
Expires: 1975-08-30
Abstract
No abstract record available.
Inventors
- 👤 Haack Erich
- 👤 Hagedorn Adolf
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-08 14:04
CPC Classifications
C; C07; C07C; C07C311/00; C07C311/50; C07C311/52; C07C311/54
Claims Analysis
Total Claims: 1
Claim 1
Independent Claim
39 words
AN ANTIDIABETIC COMPOSITION SUITABLE FOR ORAL ADMINISTRATION, SAID COMPOSITION COMPRISING A PHARMACEUTICAL CARRIER AND, AS ANTIDIABETIC AGENT, NOT LESS THAN 5% OF AN N1-SULFANILY-N2-SUBSTITUTED UREA COMPOUND SELECTED FROM THE GROUP CONSISTING OF N1-SULFANILY-N2 ALKYL UREA COMPOUNDS OF THE FORMULA
References Cited (Backward Citations)
US2371178A
Cited
US846895A
Cited
US2082952A
Cited
US2312404A
Cited
US2385571A
Cited
CH236178A
Cited
FR919464A
Cited
FR993465A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1962-10-05 | 1963-04-06 | 1963-10-06 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1966-10-05 | 1967-04-06 | 1967-10-06 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1970-10-05 | 1971-04-06 | 1971-10-06 | $7700.00 | Window Closed / Lapsed |